Early Access — free while we kick the tires
EdgarHawk

Nassif Mikheal

CEO

Director Officer
4 filings analyzed · 1 company · Latest 2026-02-17

Companies

Company Buys Sells Direction
NEOGEN CORP NEOG 5 0 Net buying

Activity

February 2026
2026-02-17 NEOGEN CORP NEOG
high
Buy
23 shares
$252
Significance 6/10

CEO Nassif Mikheal bought 23 NEOG shares at $10.94 on 2026-02-17; stock at 52-week high, 90-day surge +97.3%.

CEO Nassif Mikheal purchased 23 shares of NEOGEN CORP at $10.94 on 2026-02-17, bringing his holdings to 704 shares (+3.4%). The transaction occurs as NEOG trades at its 52-week high of $10.99 with a +97.3% surge over the past 90 days and +18.8% over the past 30 days. Across his cross-ticker track record, Mikheal's prior four buys averaged a 90-day return of +63.5% with a 100% win rate, though his same-ticker history at NEOG shows mixed near-term performance (one prior buy returned +17.2% in 30 days; another returned -5.0% in 30 days). Notably, NEOG remains unprofitable with a net income of $-15.9M despite $224.7M in quarterly revenue, and the company experienced -3.2% annual revenue contraction, creating a tension between the CEO's accumulation activity and the company's operating fundamentals.

2026-02-02 NEOGEN CORP NEOG
medium
Buy
49 shares
$486
Significance 6/10

CEO Nassif Mikheal purchased 49 shares across 2 transactions totaling $486.37 at blended avg $9.93, raising stake to 681 shares.

Nassif Mikheal executed 2 separate purchases totaling 49 shares for $486.37 at an average price of $9.93, increasing his holdings by 7.8% from 632 to 681 shares. The stock has appreciated 46.4% over the past 30 days and 69.7% over 90 days, now trading at $10.25, only 11.2% below its 52-week high of $11.54. His prior buy at this ticker on 2025-11-03 generated a 90-day return of +63.5%, demonstrating a history of well-timed entry on this stock. However, NEOG fundamentals remain challenged: the company reported a quarterly revenue of $224,691,000.00 and a net loss of $-15,924,000.00, with annual revenue declining 3.2% year-over-year and full-year net income negative. The timing of these purchases within a sharp uptrend, combined with his track record of favorable 90-day outcomes at this ticker, merits investor monitoring of whether the CEO sees value after the recent rally or is simply accumulating a small position in an operationally stressed business.

January 2026
2026-01-16 NEOGEN CORP NEOG
medium
Buy
137 shares
$1,279
Significance 5/10

NEOG CEO Nassif Mikheal bought 137 shares at $9.33, raising holdings 27.7%; stock is -26.8% from 52-week high amid negative earnings.

Nassif Mikheal, CEO of Neogen Corp, purchased 137 shares at $9.33 on 2026-01-16, increasing his holdings by 27.7% to 632 shares post-transaction. The timing coincides with a notably depressed valuation relative to recent highs: the stock trades at -26.8% from its 52-week high of $12.64, though it has recovered +30.5% over 30 days and +57.3% over 90 days. However, the company's fundamentals remain challenged—net income was $-15.9M (unprofitable) in the most recent quarter, with annual revenue declining 3.2% year-over-year. The CEO's cross-ticker buy history shows limited precision: prior open-market purchases averaged a -5.0% 30-day return, and his one prior NEOG transaction (Buy on 2025-11-03) has not yet registered a measurable 90-day outcome. This purchase represents a meaningful accumulation at current levels but occurs against a backdrop of ongoing operational losses and revenue contraction.

November 2025
2025-11-07 NEOGEN CORP NEOG
medium
Buy
177 shares
$1,106
Significance 5/10

CEO Nassif Mikheal bought 177 NEOG shares at $6.25; holdings up 55.7% to 495 shares post-transaction.

CEO Nassif Mikheal purchased 177 shares at $6.25 on 2025-11-03, increasing his holdings by 55.7% from 318 to 495 shares. The transaction occurred at a price $0.15 below the current market price of $6.40 and significantly below the 52-week high of $16.40, positioning the purchase in the lower portion of the stock's recent trading range. This open-market buy by the CEO comes amid company fundamentals marked by annual revenue decline of -3.2% and negative full-year net income, though the most recent quarter showed positive quarterly results of $209.2M revenue and $36.3M net income. The modest transaction size ($1,106.25 total value) and the company's mixed financial backdrop warrant further examination of the CEO's broader investment thesis and any forward-looking strategic initiatives.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access